Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
LB Pharmaceuticals Inc (LBRX) had Earnings per Share (EPS) (Basic) of $-0.61 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-3.56M |
|
-- |
|
-- |
|
$5.25M |
|
$-5.25M |
|
$1.69M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-5.25M |
|
$-5.25M |
|
5.81M |
|
5.81M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.61 |
$-0.61 |
|
| Balance Sheet Financials | |
$316.40M |
|
$1.64M |
|
$4.34M |
|
$320.75M |
|
$6.65M |
|
-- |
|
$3.88M |
|
$10.53M |
|
$310.22M |
|
$310.22M |
|
$310.22M |
|
25.30M |
|
| Cash Flow Statement Financials | |
$-17.11M |
|
$-39.85M |
|
$303.73M |
|
$23.48M |
|
$270.26M |
|
$246.78M |
|
$1.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
47.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1.15% |
|
-1.15% |
|
-1.11% |
|
-1.15% |
|
$12.26 |
|
$-2.95 |
|
$-2.95 |
|